z-logo
Premium
Characterization of serine/cysteine protease inhibitor α 1 ‐antitripsin from meconium‐instilled rabbit lungs
Author(s) -
Zagariya A.M.,
Bhat R.,
Zhabotynsky E.,
Chari G.,
Navale S.,
Xu Q.,
Keiderling T.A.,
Vidyasagar D.
Publication year - 2005
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.20492
Subject(s) - serpin , neutrophil elastase , slpi , serine proteinase inhibitors , serine protease , protease inhibitor (pharmacology) , inflammation , meconium , serine , lung , elastase , biology , microbiology and biotechnology , chemistry , immunology , protease , biochemistry , enzyme , medicine , fetus , gene , virus , pregnancy , genetics , antiretroviral therapy , viral load
We have recently purified from meconium‐instilled rabbit lungs a novel serine proteinase inhibitor, with an apparent molecular mass of 50 kDa, which we assign to be α 1 ‐antitripsin. We hypothesize that serpin may attenuate pulmonary inflammation and improve surfactant function after meconium aspiration. α 1 ‐antitripsin is a member of the proteinase inhibitor (serpin) superfamily and inhibitor of neutrophil elastase, and it can be identified as a member of the family by its amino acid sequence due to the high degree of conserved residues. α 1 ‐antitripsin is synthesized by epithelial cells, macrophages, monocytes, and neutrophils. Deficiency in α 1 ‐antitripsin leads to exposure of lungs to uncontrolled proteolytic attack from neutrophil elastase or other damaging factors culminating in lung destruction and cell apoptosis. We hypothesize that accumulation of α 1 ‐antitripsin in the lungs serves as a predisposed protection against meconium‐induced lung injury. In this paper, we show how this knowledge can lead to the development of novel therapeutic approaches for treatment of MAS. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom